Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Accounts Payables (2019 - 2025)

Avai Bio's Accounts Payables history spans 6 years, with the latest figure at $1.1 million for Q1 2024.

  • On a quarterly basis, Accounts Payables rose 356.65% to $1.1 million in Q1 2024 year-over-year; TTM through Mar 2024 was $1.1 million, a 356.65% increase, with the full-year FY2024 number at $1.1 million, up 356.65% from a year prior.
  • Accounts Payables hit $1.1 million in Q1 2024 for Avai Bio, up from $850000.0 in the prior quarter.
  • Over the last five years, Accounts Payables for AVAI hit a ceiling of $1.1 million in Q3 2020 and a floor of $1986.0 in Q1 2022.
  • Historically, Accounts Payables has averaged $330622.9 across 5 years, with a median of $129760.0 in 2023.
  • Biggest five-year swings in Accounts Payables: plummeted 99.27% in 2022 and later soared 11828.55% in 2023.
  • Tracing AVAI's Accounts Payables over 5 years: stood at $444502.0 in 2020, then crashed by 39.05% to $270923.0 in 2021, then plummeted by 67.89% to $87001.0 in 2022, then soared by 877.0% to $850000.0 in 2023, then increased by 27.27% to $1.1 million in 2024.
  • Business Quant data shows Accounts Payables for AVAI at $1.1 million in Q1 2024, $850000.0 in Q4 2023, and $138510.0 in Q3 2023.